Actively Recruiting
Role of Regulatory B Cells in the Pathogenesis of Metabolic Associated Fatty Liver Disease
Led by Assiut University · Updated on 2024-07-30
174
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate the role of regulatory B cells in the pathogenesis of metabolic associated fatty liver disease patients.
CONDITIONS
Official Title
Role of Regulatory B Cells in the Pathogenesis of Metabolic Associated Fatty Liver Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients older than 18 years diagnosed with fatty liver based on clinical examination, lab tests, and imaging techniques
You will not qualify if you...
- Patients 18 years old or younger
- Pregnancy
- Presence of cancer (malignancy)
- Having type 1 diabetes mellitus
- Fatty liver patients currently treated with statins or other medications
- Fatty liver patients who have undergone bariatric surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medicine
Asyut, Egypt
Actively Recruiting
Research Team
A
Amira Mohamed, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here